News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Nirmatrelvir-ritonavir cuts disease progression, viral load in unvaccinated COVID-19 outpatients
04 May 2022
byAudrey Abella
In the phase II/III EPIC-HR* trial, the novel oral antiviral nirmatrelvir-ritonavir reduced the risk of progression of COVID-19 to severe disease, as well as viral load, in symptomatic, high-risk, unvaccinated nonhospitalized adults confirmed to have SARS-CoV-2 infection.
04 May 2022

Narrow- vs broad-spectrum antibiotics: Which is better for older AECOPD patients?
03 May 2022
Use of either empiric broad- or narrow-spectrum antibiotics in older patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) shows no remarkable difference in the primary outcome, reports a recent study.
03 May 2022






